Skip to content
drillr.ai

BBNX

Beta Bionics, Inc.

NASDAQ · USHealthcareMedical - Equipment & Services
$17.82+3.07%

Price as of Jul 20, 2026

BBNX news

Beta Bionics, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders

    Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders PR Newswire SAN DIEGO, July 1, 2026 SAN DIEGO, July 1, 2026 /PRNewswire/ -- Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Beta Bionics, Inc. (NASDAQ: BBNX). The investigation concerns whether Beta Bionics or certain of its executive officers made false or misleading statements, or failed to disclose material information, concerning the Company's growth tr

    PR Newswire ·

  2. Johnson Fistel Continues Investigation of Beta Bionics, Inc. (BBNX)

    Johnson Fistel Continues Investigation of Beta Bionics, Inc. (BBNX) Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Beta Bionics, Inc. (NASDAQ: BBNX). The investigation concerns whether Beta Bionics or certain of its executive officers made false or misleading statements, or failed to disclose material information, concerning the Company’s growth trends, new patient starts, business outlook, and related operating metrics. Beta Bionics Investo

    Business Wire ·

  3. Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth

    Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth PR Newswire SAN DIEGO, June 12, 2026 SAN DIEGO, June 12, 2026 /PRNewswire/ -- Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Beta Bionics, Inc. (NASDAQ: BBNX). The investigation concerns whether Beta Bionics or certain of its executive officers made false or misleading statements, or failed to disclose material info

    PR Newswire ·

  4. BBNX Investor Notice: Robbins LLP Reminds Beta Bionics, Inc. That it is Investigating The Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders

    SAN DIEGO, CA / ACCESS Newswire (https://www.accessnewswire.com/) / June 4, 2026 / Shareholder rights law firm Robbins LLP (https://pr.report/m8ay) is investigating Beta Bionics, Inc. (NASDAQ:BBNX) to determine whether certain Beta Bionics officers and directors violated securities laws and breached fiduciary duties to shareholders. Beta Bionics is a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality o

    ACCESSWIRE ·

  5. Beta Bionics, Inc. (BBNX) Investigation: Johnson Fistel Investigates Investor Losses Following Slower New Patient Start Growth

    SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether Beta Bionics, Inc. (NASDAQ: BBNX) or certain of its executive officers violated federal securities laws. If you purchased Beta Bionics securities and suffered losses on your investment, join our investigation now: Click Here to Join the Investigation (https://www.globenewswire.com/Tracker?data=3osQS6cA9SoYT7DZ42c2M-WhTJwBtW28-0BdYDSeqSsgjuA_zGFUQ6VhVRTlxkTAl7hI4L4P8FQERAl3Bwv9PAKTR5Zrxe9QHvxDe8g43bHaPL7Ei

    Globe Newswire ·

  6. Beta Bionics, Inc. Securities Fraud Investigation – Robbins LLP is Investigating Investor Losses in BBNX Due to Possible Violations of Securities Laws

    SAN DIEGO, June 03, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP (https://www.globenewswire.com/Tracker?data=qNBBT6L_aftc9VKqbXpcKciBpk7-G6n17BS_NfyrE-TXaERd7EjXsef0xpf3KjbGJKcpeHPI4CnJYctLNnl7DStkwjzh0Tem8jakW7rPXk4=) is investigating Beta Bionics, Inc. (NASDAQ: BBNX) to determine whether certain Beta Bionics officers and directors violated securities laws and breached fiduciary duties to shareholders. Beta Bionics is a commercial-stage medical device company, engages in the

    Globe Newswire ·

  7. Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel

    Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel Johnson Fistel, PLLP is investigating whether Beta Bionics, Inc. (NASDAQ: BBNX) or certain of its executive officers violated federal securities laws. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Beta Bionics securities? If you purchased Beta Bionics securities and suffered losses o

    Business Wire ·

  8. BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders

    BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders PR Newswire SAN DIEGO, June 2, 2026 SAN DIEGO, June 2, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4702371-1&h=76077859&u=https%3A%2F%2Frobbinsllp.com%2Fbeta-bionics-inc%2F&a=Robbins+LLP)  is investigat

    PR Newswire ·

  9. Beta Bionics Investors Who Suffered Losses May Be Eligible for Recovery-Learn More Today, Contact Johnson Fistel

    San Diego, California--(Newsfile Corp. - June 2, 2026) - Johnson Fistel, PLLP is investigating whether Beta Bionics, Inc. (NASDAQ: BBNX) or certain of its executive officers violated federal securities laws. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. What if I purchased Beta Bionics securities? If you purchased Beta Bionics securities and suffered losses on your investment, join our investigation now: Click Here to Join the I

    Newsfile Corp ·

  10. Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders

    Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders Shareholder Rights law firm Robbins LLP (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Frobbinsllp.com%2Fbeta-bionics-inc%2F&esheet=54545758&newsitemid=20260601622921&lan=en-US&anchor=Robbins%20LLP&index=63&md5=98c63a187f7ceb73baa952fccd63163e) is investigating Beta Bionics, Inc. (NASDAQ: BBNX) to determin

    Business Wire ·

  11. Beta Bionics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses

    SAN DIEGO, June 01, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether Beta Bionics, Inc. (NASDAQ: BBNX) or certain of its executive officers violated federal securities laws. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Beta Bionics securities? If you purchased Beta Bionics securities and suffered losses on your investment, join our investigation now: Click Here to Join the Investigation

    Globe Newswire ·

  12. Beta Bionics to Present at the Bank of America Securities Health Care Conference

    IRVINE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities Health Care Conference in Las Vegas on Tuesday, May 12, 2026 at 2:20 pm Eastern Time (11:20 am Pacific Time). A live audio webcast of the presentation will be available on the Company’s website in the “Investors—Events & Presentations” section at https

    Globe Newswire ·

  13. Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

    IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended March 31, 2026 and raised its full year guidance for the year ending December 31, 2026. First Quarter 2026 Financial Highlights & Key Metrics * Net sales of $27.6 million, up 57% compared to $17.6 million in the first quarter of 2025. * Durable Medical Equipment (DME) cha

    Globe Newswire ·

  14. Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care

    IRVINE, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Beta Bionics today announced the launch of Bionic Insights™, an innovative new feature within its Bionic Reports, designed to help healthcare providers (HCPs) make more informed, personalized treatment recommendations for people living with diabetes. As the first and only insulin pump company to deliver this level of intelligent reporting, Beta Bionics is redefining how clinicians interpret patient data. Bionic Insights goes beyond traditional g

    Globe Newswire ·

  15. BBNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics

    BBNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics PR Newswire NEW YORK, March 28, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4651743-1&h=3777689607&u=https%3A%2F%2Fwww.faruqilaw.com%2Fattorney%2F22%2Fjames-m-wilson-jr&a=James+(Josh)+Wilson) Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Opt

    PR Newswire ·

  16. BBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics

    Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson (https://www.globenewswire.com/Tracker?data=F6aG24PpFJpGIXYsB2PpN3objqzlqIapMLZvLid5V4uZ9upX2bePYk6peOtQrl4n4u07Z3GR4-uLz0Xz7C6Z1p4K3mO3DZ77duFFUkaxp3ybM3OqkhUv6BTUp5c5u5yrJlmoZ2ze51qT26_cejUAzQ==) Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Options If you suffered significant losses in Beta Bionics (https://www.globenewswire.com/Tracker?data=u3RhZ0Gy

    Globe Newswire ·

  17. INVESTOR ALERT: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (BBNX)

    Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson (https://api.newsfilecorp.com/redirect/5WNN8HWnVP) Encourages Investors Who Suffered Significant Losses Beta Bionics (https://api.newsfilecorp.com/redirect/LqnnytG4Y7) Stock or Options To Contact Him Directly At 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] (https://api.newsfilecorp.com/redirect/oPAAQsB3wj) New York, New York--(Newsfile Corp. - March 20, 2026) - Faruqi & Faruqi

    Newsfile Corp ·

  18. ONGOING INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Beta Bionics (NASDAQ: BBNX)

    Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson (https://www.globenewswire.com/Tracker?data=4qBwiwU18mhs7IBdL79f2jNYiOaYu2_Qc_zwsGDw9cMda74nRmN4naRy9VkiUOVIO0ahHmZSMC2OIlob0OfmckrZgbD-ZefLwwJrlbSih6oZCnD3_HqYEnzW-sLB1OXaNaJF7myVYnd_Iy6Fxlr48Q==) Encourages Investors Who Suffered Significant Losses Beta Bionics (https://www.globenewswire.com/Tracker?data=pmTKFve3sVoIJ9wAWNSUkLbv6K0MMS8R_qztKETqK5_I4P4dDfxSNftIoK37oQHOHtWKa2DXcNwjsYBIGH-nM-EUdgr7DvHSZiS7Alus-Ko=) Stock or Op

    Globe Newswire ·

  19. SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (NASDAQ: BBNX)

    SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (NASDAQ: BBNX) PR Newswire NEW YORK, March 17, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson (https://edge.prnewswire.com/c/link/?t=0&l=en&o=4643259-1&h=3717873850&u=https%3A%2F%2Fwww.faruqilaw.com%2Fattorney%2F22%2Fjames-m-wilson-jr&a=James+(Josh)+Wilson) Encourages Investors Who Suffered Significant Losses In Beta Bionics To Contact Him D

    PR Newswire ·

  20. BBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics

    Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson (https://www.globenewswire.com/Tracker?data=z4u_fnPdy3sn336BqzoCYE0FLfjWx3YzN1SNI9C8LLv53VWoxcM3DdHAPqNhNFiGn-1FWIwN-n92C_XGZuIDGGF1-E_mdY89_BhIuL_OYm3WVYuTAY4AFKEVIVbHv74WHRcbThgpvk3trwqT_a7b7A==) Encourages Investors Who Suffered Significant Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you suffered significant losses in Beta Bionics (https://www.globenewswire.com/Tracker?data=_jd8GhUfsA29pRyNAb

    Globe Newswire ·